Benzinga··Vandana SinghMedtronic Exceeds Q3 Sales Targets, Maintains Full-Year Growth Guidance
Medtronic beat Q3 sales estimates at $9.02B with 8.7% growth, reaffirming full-year guidance. Strong cardiovascular and diabetes segments drove performance despite stock decline.
MDTorganic growthrevenue beat